Literature DB >> 18384937

Thyroid fine needle aspiration: how to improve clinicians' confidence and performance with the technique.

A Carpi1, G Di Coscio, G Iervasi, A Antonelli, J Mechanick, S Sciacchitano, A Nicolini.   

Abstract

Studies from single institutions report an acceptable accuracy rate for thyroid fine needle aspiration (FNA). However, FNA accuracy is much lower in many other centers in Europe and the USA and large multicenter studies indicate that the clinicians' confidence in the FNA technique remains low. One explanation for this is that there is an excess of inadequate and indeterminate findings for a follicular nodule at FNA cytology. In a University Hospital with large and qualified experience on thyroid nodule diagnosis, a review of 320 slides with an FNA diagnosis of indeterminate follicular nodule from different minor Italian Hospitals led to a different diagnosis in 61%. Since ancillary thyroid imaging may be overutilized and only a few authors report a proportion of excised nodules lower than 10%, we suspect that use of the FNA procedure is suboptimal. Several techniques are reported to improve the performance of thyroid FNA. Among these are tumor markers and large needle aspiration biopsy (LNAB). Immunodetection of the tumor marker galectin-3 has been evaluated by large multinational studies. Analysis of LNAB specimens reduces the number of inadequate FNA findings, improves the diagnostic determination of indeterminate follicular FNA findings and represents a better substrate for the determination of galectin-3. Therefore, we propose that clinical practice guidelines reflect these adjuvant techniques to thyroid FNA in order to improve selection criteria for thyroid nodule surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18384937     DOI: 10.1016/j.canlet.2008.02.056

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Development of a clinical decision model for thyroid nodules.

Authors:  Alexander Stojadinovic; George E Peoples; Steven K Libutti; Leonard R Henry; John Eberhardt; Robin S Howard; David Gur; Eric A Elster; Aviram Nissan
Journal:  BMC Surg       Date:  2009-08-10       Impact factor: 2.102

2.  Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.

Authors:  Anthony K-C So; Jatinder Kaur; Ipshita Kak; Jasmeet Assi; Christina MacMillan; Ranju Ralhan; Paul G Walfish
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

3.  Does large needle aspiration biopsy add pain to the thyroid nodule evaluation?

Authors:  Angelo Carpi; Giuseppe Rossi; Andrea Nicolini; Giorgio Iervasi; Matteo Russo; Jeffrey Mechanick
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

Review 4.  Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.

Authors:  Salvatore Sciacchitano; Luca Lavra; Alessandra Morgante; Alessandra Ulivieri; Fiorenza Magi; Gian Paolo De Francesco; Carlo Bellotti; Leila B Salehi; Alberto Ricci
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

5.  Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.

Authors:  Chia-Chun Wu; Jen-Der Lin; Jeng-Ting Chen; Chih-Min Chang; Hsiao-Fen Weng; Chuen Hsueh; Hui-Ping Chien; Jau-Song Yu
Journal:  Oncotarget       Date:  2018-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.